Aptima
Device
Gen-Probe, Inc.
Total Payments
$6.6M
Transactions
1,487
Doctors
1,064
Companies
5
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2022 | $2.9M | 100 | 0 |
| 2021 | $667,715 | 25 | 0 |
| 2020 | $679,014 | 153 | 71 |
| 2019 | $217,126 | 206 | 185 |
| 2018 | $1.3M | 291 | 196 |
| 2017 | $845,892 | 712 | 637 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $6.6M | 339 | 99.3% |
| Food and Beverage | $30,407 | 1,125 | 0.5% |
| Travel and Lodging | $13,164 | 21 | 0.2% |
| Education | $1,636 | 2 | 0.0% |
Payments by Type
Research
$6.6M
339 transactions
General
$45,207
1,148 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| A10810-ATVPS-CSP | Gen-Probe, Inc. | $1.8M | 0 |
| A10924-VAGPS-CSP-01 | Gen-Probe, Inc. | $1.1M | 2 |
| Year 2: Surveillance for Mycoplasma genitalium in US Sexually Transmitted Disease (STD) Clinics | Gen-Probe, Inc. | $504,626 | 0 |
| P10940-SC2/FluPF-CSP-01 | Gen-Probe, Inc. | $364,975 | 0 |
| P10934-CMVPS-CSP-01 | Gen-Probe, Inc. | $348,931 | 0 |
| A10417-AC2PS-CSP-02 | HOLOGIC INC | $342,324 | 0 |
| D0317001 | Gen-Probe, Inc. | $286,004 | 0 |
| Year 1: Surveillance for Mycoplasma genitalium in US Sexually Transmitted Disease (STD) Clinics | Gen-Probe, Inc. | $259,982 | 0 |
| Validation of Hologic-Developed Analyte Specific Reagents (ASR) for Detection of Genetic Markers of Macrolide Resistance in Mycoplasma genitalium | Gen-Probe, Inc. | $193,561 | 0 |
| ABCTV01-SP-01 | Gen-Probe, Inc. | $167,679 | 0 |
| P fFN 10Q01 Quant Study Site Fee | HOLOGIC INC | $132,660 | 0 |
| V10432-HIVOPS-CSP-02 | Gen-Probe, Inc. | $115,576 | 0 |
| Clinical Evaluation of the Aptima HBV Quant Assay for Hepatitis B Virus DNA Quantification on Panther System | HOLOGIC INC | $115,100 | 0 |
| Planned Parenthood Affiliate Initiated STI Research Studies | Gen-Probe, Inc. | $91,445 | 0 |
| Digital Diagnostics Feasibility Study | Gen-Probe, Inc. | $79,070 | 0 |
| Clinical Evaluation of the Aptima HCV Quant Assay for Hepatitis C Virus RNA Quantification on Panther System | HOLOGIC INC | $76,100 | 0 |
| A10417-AC2PC-CSP-02 | HOLOGIC INC | $73,610 | 0 |
| ACT2PS-US-12-003b | Gen-Probe, Inc. | $69,759 | 0 |
| ABCTV01-SP-01 | HOLOGIC INC | $60,950 | 2 |
| Rectal and Pharyngeal GCCT Testing in Patients with Cervixes | Gen-Probe, Inc. | $60,827 | 0 |
Top Doctors Receiving Payments for Aptima — Page 2
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| , MD | Maternal & Fetal Medicine | Houston, TX | $128.47 | 1 |
| , DO | Family Medicine | Jeffersonville, IN | $127.63 | 1 |
| , MD | Obstetrics | Jeffersonville, IN | $127.63 | 1 |
| , M.D | Internal Medicine | Jeffersonville, IN | $127.63 | 1 |
| Charles Dubin | Gynecology | Los Angeles, CA | $127.63 | 1 |
| , MD | Obstetrics & Gynecology | Springdale, AR | $124.89 | 2 |
| , M.D | Obstetrics & Gynecology | Shawnee Mission, KS | $123.60 | 1 |
| , M.D | Family Medicine | Kansas City, MO | $123.60 | 1 |
| , MD | Anatomic Pathology & Clinical Pathology | Overland Park, KS | $123.60 | 1 |
| , MD | Obstetrics & Gynecology | Kansas City, KS | $123.60 | 1 |
| , M.D | Obstetrics & Gynecology | Bridgeton, MO | $123.60 | 1 |
| , M.D | Student in an Organized Health Care Education/Training Program | North Kansas City, MO | $123.60 | 1 |
| , M.D | Obstetrics & Gynecology | Shawnee Mission, KS | $123.60 | 1 |
| , M.D | Student in an Organized Health Care Education/Training Program | Kansas City, MO | $123.60 | 1 |
| , M.D | Obstetrics & Gynecology | Shawnee Mission, KS | $123.60 | 1 |
| , MD | Maternal & Fetal Medicine | Overland Park, KS | $123.60 | 1 |
| , D.O | Gynecology | Shawnee Mission, KS | $123.60 | 1 |
| , MD | Obstetrics & Gynecology | Kansas City, MO | $123.60 | 1 |
| , MD | Obstetrics & Gynecology | Lees Summit, MO | $123.60 | 1 |
| , DO | Family Medicine | Fontana, CA | $123.54 | 1 |
| Karen Mckeown | — | Fontana, CA | $123.54 | 1 |
| , MD | Family Medicine | Seattle, WA | $121.95 | 1 |
| , MD | Gynecology | San Juan, PR | $115.38 | 1 |
| , M.D | Obstetrics & Gynecology | Durham, NC | $114.63 | 3 |
| , M.D | Obstetrics & Gynecology | Ponce, PR | $113.26 | 2 |
Ad
Manufacturing Companies
- Gen-Probe, Inc. $5.8M
- HOLOGIC INC $845,892
- Hologic, LLC $9,488
- Gen-Probe Sales & Service, Inc. $1,494
- Cytyc Surgical Products, LLC $237.00
Product Information
- Type Device
- Total Payments $6.6M
- Total Doctors 1,064
- Transactions 1,487
About Aptima
Aptima is a device associated with $6.6M in payments to 1,064 healthcare providers, recorded across 1,487 transactions in the CMS Open Payments database. The primary manufacturer is Gen-Probe, Inc..
Payment data is available from 2017 to 2022. In 2022, $2.9M was paid across 100 transactions to 0 doctors.
The most common payment nature for Aptima is "Unspecified" ($6.6M, 99.3% of total).
Aptima is associated with 20 research studies, including "A10810-ATVPS-CSP" ($1.8M).